Clinical trials
Completed Phase 2 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
181 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 4 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 8 |
| 2014 | 5 |
| 2015 | 16 |
| 2016 | 12 |
| 2017 | 12 |
| 2018 | 9 |
| 2019 | 23 |
| 2020 | 12 |
| 2021 | 20 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 181 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 9 |
| Gilead Sciences | 8 |
| Pfizer | 6 |
| AstraZeneca | 4 |
| Bristol-Myers Squibb | 4 |
| Merck Sharp & Dohme LLC | 4 |
| University of California, San Diego | 4 |
| Zydus Therapeutics Inc. | 4 |
| Akero Therapeutics, Inc | 3 |
| Massachusetts General Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 181 |
| Fatty Liver | 30 |
| Diabetes Mellitus, Type 2 | 13 |
| Fibrosis | 13 |
| Liver Diseases | 13 |
| Insulin Resistance | 12 |
| Obesity | 12 |
| Liver Cirrhosis | 10 |
| Diabetes Mellitus | 9 |
| Digestive System Diseases | 6 |
Trials
Showing 1 to 25 of 181. Each trial links to its page on Pharma Observatory.
81 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.